CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy.
Publication
, Journal Article
Jenks, JD; Hoenigl, M
Published in: J Lab Precis Med
February 2018
Duke Scholars
Published In
J Lab Precis Med
DOI
EISSN
2519-9005
Publication Date
February 2018
Volume
3
Location
China
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jenks, J. D., & Hoenigl, M. (2018). CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med, 3. https://doi.org/10.21037/jlpm.2018.01.10
Jenks, Jeffrey Daniel, and Martin Hoenigl. “CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy.” J Lab Precis Med 3 (February 2018). https://doi.org/10.21037/jlpm.2018.01.10.
Jenks JD, Hoenigl M. CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med. 2018 Feb;3.
Jenks, Jeffrey Daniel, and Martin Hoenigl. “CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy.” J Lab Precis Med, vol. 3, Feb. 2018. Pubmed, doi:10.21037/jlpm.2018.01.10.
Jenks JD, Hoenigl M. CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med. 2018 Feb;3.
Published In
J Lab Precis Med
DOI
EISSN
2519-9005
Publication Date
February 2018
Volume
3
Location
China
Related Subject Headings
- 3202 Clinical sciences